Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Cannot redeclare control with same name "grid_1_qv_typography_typography"
Cognitive function in a randomized trial of evolocumab
doi: 10.1016/J.JAGP.2023.08.010 29 LiYPerryTKindyMSHarveyBKTweedieDHollowayHWet al
Retatrutide is an investigational triple agonist peptide that targets three key metabolic receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
27 Frias JP, Davies MJ, Rosenstock J, et al
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
